Literature DB >> 10227391

Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts?

D C Rubinsztein1, A Wyttenbach, J Rankin.   

Abstract

The largest group of currently known trinucleotide repeat diseases is caused by (CAG)n repeat expansions. These (CAG)n repeats are translated into polyglutamine tracts from both mutant and wild type alleles. Genetic and transgenic mouse data suggest that the expanded polyglutamines cause disease by conferring a novel deleterious gain of function on the mutant protein. These mutations are associated with the formation of intracellular inclusions. This review will consider findings from necropsy studies of human patients and transgenic mouse models of these diseases, along with in vitro models, in order to try to synthesise the current understanding of these diseases and the evidence for and against inclusion formation as a primary mechanism leading to pathology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227391      PMCID: PMC1734357     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  33 in total

1.  Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract.

Authors:  C L Wellington; L M Ellerby; A S Hackam; R L Margolis; M A Trifiro; R Singaraja; K McCutcheon; G S Salvesen; S S Propp; M Bromm; K J Rowland; T Zhang; D Rasper; S Roy; N Thornberry; L Pinsky; A Kakizuka; C A Ross; D W Nicholson; D E Bredesen; M R Hayden
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

2.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.

Authors:  D Martindale; A Hackam; A Wieczorek; L Ellerby; C Wellington; K McCutcheon; R Singaraja; P Kazemi-Esfarjani; R Devon; S U Kim; D E Bredesen; F Tufaro; M R Hayden
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.

Authors:  M Holmberg; C Duyckaerts; A Dürr; G Cancel; I Gourfinkel-An; P Damier; B Faucheux; Y Trottier; E C Hirsch; Y Agid; A Brice
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

4.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

Authors:  C J Cummings; M A Mancini; B Antalffy; D B DeFranco; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

5.  Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat.

Authors:  Christine M Ambrose; Mabel P Duyao; Glenn Barnes; Gillian P Bates; Carol S Lin; Jayalakshmi Srinidhi; Sarah Baxendale; Holger Hummerich; Hans Lehrach; Michael Altherr; John Wasmuth; Alan Buckler; Deanna Church; David Housman; Mary Berks; Gos Micklem; Richard Durbin; Alan Dodge; Andrew Read; James Gusella; Marcy E MacDonald
Journal:  Somat Cell Mol Genet       Date:  1994-01

6.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

7.  Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

Authors:  J M Warrick; H L Paulson; G L Gray-Board; Q T Bui; K H Fischbeck; R N Pittman; N M Bonini
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

8.  Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine.

Authors:  P Kahlem; H Green; P Djian
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

9.  Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease.

Authors:  R J Ferrante; N W Kowall; M F Beal; J B Martin; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1987-01       Impact factor: 3.685

10.  The influence of huntingtin protein size on nuclear localization and cellular toxicity.

Authors:  A S Hackam; R Singaraja; C L Wellington; M Metzler; K McCutcheon; T Zhang; M Kalchman; M R Hayden
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

View more
  15 in total

1.  Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.

Authors:  Sabrina Mosaheb; Julian R Thorpe; Lida Hashemzadeh-Bonehi; Eileen H Bigio; Marla Gearing; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2005-07-16       Impact factor: 17.088

Review 2.  Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.

Authors:  Polina Egorova; Elena Popugaeva; Ilya Bezprozvanny
Journal:  Semin Cell Dev Biol       Date:  2015-04-04       Impact factor: 7.727

Review 3.  Huntington's Disease.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

4.  Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.

Authors:  Philipp Koch; Peter Breuer; Michael Peitz; Johannes Jungverdorben; Jaideep Kesavan; Daniel Poppe; Jonas Doerr; Julia Ladewig; Jerome Mertens; Thomas Tüting; Per Hoffmann; Thomas Klockgether; Bernd O Evert; Ullrich Wüllner; Oliver Brüstle
Journal:  Nature       Date:  2011-11-23       Impact factor: 49.962

5.  Intracellular green fluorescent protein-polyalanine aggregates are associated with cell death.

Authors:  J Rankin; A Wyttenbach; D C Rubinsztein
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

6.  Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.

Authors:  A Wyttenbach; J Carmichael; J Swartz; R A Furlong; Y Narain; J Rankin; D C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Modeling pathogenesis of Huntington's disease with inducible neuroprogenitor cells.

Authors:  G Dong; J M Ferguson; A J Duling; R G Nicholas; D Zhang; K Rezvani; S Fang; M J Monteiro; S Li; X-J Li; H Wang
Journal:  Cell Mol Neurobiol       Date:  2011-03-31       Impact factor: 5.046

8.  Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease.

Authors:  J Carmichael; J Chatellier; A Woolfson; C Milstein; A R Fersht; D C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 9.  The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.

Authors:  R Walsh; E Storey; D Stefani; L Kelly; V Turnbull
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

10.  A molecular investigation of true dominance in Huntington's disease.

Authors:  Y Narain; A Wyttenbach; J Rankin; R A Furlong; D C Rubinsztein
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.